The authors report on the results of the Collaborative Bleb-related Incidence and Treatment Study (CBIITS), which was a five year multi-centre prospective study designed to investigate the incidence of bleb-related infection following filtering surgery with mitomycin C. In this study, bleb-related infection was defined as an infection that: (1) followed trabeculectomy or phaco-trabeculectomy, (2) occurred four weeks post-surgery, and (3) demonstrates clinical signs of infection related to a filtering bleb. Patients were followed up every six months for five years. A total of 1098 eyes (1098 patients) were suitable for inclusion in the study, with 824 eyes completing the five year follow-up or reached the end point of developing bleb-related infection. While 916 eyes underwent trabeculectomy alone, 182 eyes had phaco-trabeculectomy. Of these eyes, 21 developed bleb-related infection, occurring 27.3±15.9 months after surgery. The cumulative incidence of all bleb-related infection was 2.2±0.5% over the five year follow-up, while the cumulative incidence of bleb-related endophthalmitis was 1.1±0.3%. There was no difference between trabeculectomy alone or phaco-trabeculectomy, and no difference between fornix-based and limbal-based surgery. The main risk factor for infection was bleb leak (cumulative incidence 7.9±3.1%). This is the largest study to date evaluating the incidence of bleb-related infection following mitomycin C trabeculectomy. It confirms not only the relative safety of using mitomycin-C, but also the importance of long-term monitoring for bleb leak after filtering surgery. 

The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C.
Yamamoto T, Sawada A, Mayama C, et al.
Share This
Brian Ang

Royal Victorian Eye and Ear Hospital, Melbourne, Australia

View Full Profile